OSE Immunotherapeutics gets new US patent for Tedopi in cancer patients
The patent is said to validate the unique combination of multiepitope that is given to patients with HLA-A2…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Jul 23
The patent is said to validate the unique combination of multiepitope that is given to patients with HLA-A2…
05 Jul 23
Under the agreements, Samsung Biologics will manufacture biosimilar products ranging from oncology and inflammation to immunotherapy in the…
05 Jul 23
In the trial, most patients who received JNJ-2113 achieved the primary endpoint of Psoriasis Area and Severity Index…
05 Jul 23
The pivotal clinical trial approved in China will evaluate the efficacy and safety of Glecirasib as a single…
05 Jul 23
pitolisant is the first and only treatment drug approved in mainland China for narcolepsy
04 Jul 23
The list price for HULIO is 5% less than the current list price of the rheumatoid arthritis drug…
04 Jul 23
Launches authorized generic for Xyrem (sodium oxybate) in the US, representing another new complex generic product launch
03 Jul 23
The consideration includes $1.75bn in upfront cash and up to $750m in the form of potential milestone payments…
03 Jul 23
The approval in China was based on the results from the global Phase 3 ADAPT trial in which…
03 Jul 23
Both firms decided to voluntarily withdraw the US RET-mutant MTC indication following consultation with the FDA, as the…